|
TXNDC15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22649676473452E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.35445038202442E-12 |
| Normal-vs-Stage2 |
6.696900E-03 |
| Normal-vs-Stage3 |
7.180000E-04 |
| Normal-vs-Stage4 |
4.479300E-03 |
| Stage1-vs-Stage2 |
8.478200E-01 |
| Stage1-vs-Stage3 |
2.186400E-01 |
| Stage1-vs-Stage4 |
6.062300E-02 |
| Stage2-vs-Stage3 |
5.659200E-01 |
| Stage2-vs-Stage4 |
3.599200E-01 |
| Stage3-vs-Stage4 |
6.087400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79289916246717E-11 |
| Normal-vs-AfricanAmerican |
1.597720E-02 |
| Normal-vs-Asian |
1.757570E-01 |
| Caucasian-vs-AfricanAmerican |
2.766200E-01 |
| Caucasian-vs-Asian |
4.893400E-01 |
| AfricanAmerican-vs-Asian |
7.717800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.86239999480742E-08 |
| Normal-vs-Female |
6.11710015974154E-10 |
| Male-vs-Female |
1.792780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.997200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.58199994507669E-09 |
| Normal-vs-Age(61-80Yrs) |
4.05569999806232E-08 |
| Normal-vs-Age(81-100Yrs) |
9.855200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.865750E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.174500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.043900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.279800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.702200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.447190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.21199999720312E-08 |
| Normal-vs-Grade 2 |
9.16320352928324E-11 |
| Normal-vs-Grade 3 |
1.23870000034998E-07 |
| Normal-vs-Grade 4 |
9.400200E-02 |
| Grade 1-vs-Grade 2 |
3.736000E-01 |
| Grade 1-vs-Grade 3 |
7.695600E-02 |
| Grade 1-vs-Grade 4 |
1.084370E-02 |
| Grade 2-vs-Grade 3 |
1.278380E-01 |
| Grade 2-vs-Grade 4 |
4.166200E-04 |
| Grade 3-vs-Grade 4 |
1.795780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
1.036760E-01 |
| ccA subtype-vs-ccB subtype |
1.79769998887025E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.03779999991194E-07 |
| Normal-vs-N1 |
3.819600E-01 |
| N0-vs-N1 |
4.046600E-01 |
|
|
